Document Detail


Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997.
MedLine Citation:
PMID:  11535997     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiac complications may result from high-dose chemotherapy or irradiation administered during the conditioning phase of bone marrow and blood stem cell transplantation (BMT). To assess the frequency of clinically serious cardiac toxicity related to the acute phase of BMT, we retrospectively examined life-threatening or fatal cardiotoxicity identified using the complications records of our transplant center clinical database. All serious cardiac toxicity events within 100 days of BMT except those attributable to septic shock, pneumonitis or multi-organ failure were reviewed. Of 2821 BMT patients at the University of Minnesota between 1977 and 1997, 26 were identified as having suffered major or fatal (n = 13) cardiotoxicity (0.9%, 19 adults and seven children). Rapidly progressive heart failure resulted in death of 11 patients, one patient had fatal pericardial tamponade, and one had an acute ventricular fibrillation arrest. The remaining 13 patients (50%) had life-threatening cardiotoxicity including four patients with pericardial tamponade and nine patients with cardiac arrhythmias. Overall, we observed that acute, major cardiotoxic events attributable to BMT are uncommon, occurring with a frequency of <1%. These data suggest that with appropriate pre-transplant clinical evaluation, high-dose cyclophosphamide and irradiation in the BMT preparative phase does not result in frequent, clinically relevant short-term cardiac toxicity.
Authors:
T Murdych; D J Weisdorf
Related Documents :
15288357 - Consideration of rituximab for fibrodysplasia ossificans progressiva.
23993357 - Incidence of endophthalmitis after corneal transplant or cataract surgery in a medicare...
10789597 - Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing ...
11841457 - Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressi...
20440767 - Features of immune senescence in liver transplant recipients with established grafts.
7138157 - Reversible renal insufficiency in multiple myeloma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Bone marrow transplantation     Volume:  28     ISSN:  0268-3369     ISO Abbreviation:  Bone Marrow Transplant.     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-09-05     Completed Date:  2002-03-07     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  8702459     Medline TA:  Bone Marrow Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  283-7     Citation Subset:  IM    
Affiliation:
Blood and Marrow Transplant Program, Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / administration & dosage,  toxicity*
Bone Marrow Transplantation / adverse effects*,  methods
Child
Child, Preschool
Databases, Factual
Female
Heart Diseases / chemically induced*,  mortality
Hematologic Neoplasms / complications,  therapy
Humans
Incidence
Infant
Male
Middle Aged
Radiotherapy, Adjuvant / adverse effects
Retrospective Studies
Risk Factors
Stroke Volume
Ventricular Dysfunction, Left
Whole-Body Irradiation / adverse effects

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-do...
Next Document:  Does gastroenterology consultation change management of patients receiving hematopoietic stem cell t...